The effects of alpha- and beta-adrenoceptor blocking agents on the responses of the rat uterus to catecholamines throughout the oestrus cycle.
D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004971:Estrus; D005260:Female; D007545:Isoproterenol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011247:Pregnancy; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D013565:Sympatholytics / Q000494:pharmacology*; D014043:Tolazoline / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects*
D002395:Catecholamines; D011955:Receptors, Drug; D013565:Sympatholytics; D011433:Propranolol; D014043:Tolazoline; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine